سبيروفاك في إل 5 لقاح العطيفة البقرية واللبتوسبيرا الخماسية التناسلي للأبقار
Spirovac VL5 is an inactivated bacterin containing chemically inactivated cultures of Campylobacter fetus (vibriosis) and Leptospira canicola, L. grippotyphosa, L. hardjo (L. borgpetersenii serovar Hardjo), L. icterohaemorrhagiae, and L. pomona. Indicated for the vaccination of healthy cattle as an aid in preventing campylobacteriosis (vibriosis) and leptospirosis, including renal colonization and urinary shedding of L. hardjo.
Dosage Form
Injection
Product Type
Biological
Manufacturer
Package
Vials of 10 doses (50 mL) and 50 doses (250 mL)
| Species | Dosage | Route | Duration |
|---|---|---|---|
| Cattle | 5 mL administered subcutaneously | Subcutaneous (SC) | Initial vaccination: 2 doses administered 4 to 6 weeks apart, with the second dose given 2 to 4 weeks prior to breeding; revaccinate annually |
| Species | Meat (days) | Milk (days) | Eggs (days) |
|---|---|---|---|
| Cattle | 21 | 0 |
Vaccination of healthy cattle as an aid in preventing reproductive disease caused by Campylobacter fetus (vibriosis) and Leptospira canicola, L. grippotyphosa, L. hardjo, L. icterohaemorrhagiae, and L. pomona.
Do not vaccinate clinically sick animals.
Contains thimerosal as preservative. In case of anaphylaxis, administer epinephrine.
Transient local swelling or temporary stiffness may occur.
Spirovac VL5 Bovine Vibriosis & Leptospirosis Vaccine Prescribing Information
LeafletNo data available
Information has not been added yet.
Manufacturer
No alternatives available.